Contact
About Nucletron
About Nucletron
Company History
Nucletron Worldwide
Careers
Management Board
Resource Library
About Brachytherapy
Patient information
Products & Solutions
Type of cancer
Head & Neck
Skin & Surface
Bronchus & Esophagus
Prostate
Rectum & Bladder
Breast
Pancreas & Bile Duct
Gynecology
Type of product
Imaging
Treatment Planning
Treatment Delivery
Applicators
Service & Support
Service and Support
oncoSupport Discover
What's new and what's next in radiation oncology
oncoSupport Define
Complete planning and project management
oncoSupport Deliver
Maintain and enhance your radiation oncology solutions
oncoSupport Develop
New services and new solutions
Training & Education
Training and Education
An overview of all training and education opportunities at Nucletron
Choose Category
Application Courses
Technical Courses
Clinical Workshop
My Nucletron
Login
Login to My Nucletron
Register
Register a new account
Forgot password?
Request a new password
Home
News & Events
Uninterrupted Supply of Sources Secured in Spite of Temporary Shutdown of the Petten HFR Reactor
October 31 2008 | Uninterrupted Supply of Sources
Nucletron has been able to obtain sufficient quantities of irradiated iridium from the BR2 reactor in Mol, Belgium
Veenendaal, Netherlands (October 31, 2008) — The supply situation of iridium sources has been uncertain for some time now due to the temporary closure of the Petten (The Netherlands) HFR Reactor and the temporary lack of back-up irradiation support through other European reactors.
We are happy to report that Nucletron has been able to obtain sufficient quantities of irradiated iridium from the BR2 reactor in Mol, Belgium to cover our customer supply requirements through week 44.
Beyond week 44, Nucletron will be able to continue to provide an uninterrupted supply of sources, as we have secured the support of the Missouri University Research Reactor (MURR) in Columbia, MO, USA.
After the last closure of the Petten HFR in 2002, Nucletron took steps to secure and set-up a second supplier in the United States with the clear purpose of developing a US based irradiation services provider. This strategy is now clearly paying off.
With the combination of services supplied by Mol, MURR, and in addition to the Chalk River reactor in Kanata, Canada, Nucletron will be able to continue to supply sources as per our customer requirements, without interruption, in spite of the continued closure of the Petten HFR reactor. The latest news is that Petten will be open for business late Q1 2009.
The actions taken, as communicated through this announcement, are a direct result of Nucletron’s commitment to our customers in providing uninterrupted services, so they may continue to provide their patients with the highest level of radiation therapy service in the fight against cancer.